ARCHIVES

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

This article is from The Cancer Letter archive.

Vol. 23 No. 41 | October 24, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

September 2, 1988

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors

April 25, 1980

Health Association Oppose U.S. Trade Policy On Tobacco Exports; Recommend Restrictions

August 25, 1989